Get the app
US › Healthcare

Quidel Corporation (QDEL)

US · Healthcare · Medical Devices

$12.91-7.19%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$630.9M
Revenue YoY
+2.8%
Net profit
$-92.9M
EPS
$0.13
EPS estimate
$-0.04
Net margin
-14.7%

EPS came in at 0.13 against a street estimate of -0.04 — a beat of 425.0%.

Key statistics

Market cap
$920.3M
Forward P/E
9.6
P/B
0.42
Book value
$25.99
EPS (TTM)
$-16.64
52-week high
$35.58
52-week low
$9.92
50-day MA
$13.26
200-day MA
$17.65
Beta
0.78

Analyst view

Analysts rate Quidel Corporation a hold (1 buy, 1 hold, 1 sell out of 3) with an average price target of $14.67.

Shareholding

Insiders
0.90%
Institutions
124.27%

Largest institutional holders

FundStake
BlackRock Inc16.34%
FMR Inc10.74%
Newtyn Management LLC9.66%
Vanguard Portfolio Management, LLC6.03%
Neuberger Berman Group LLC5.15%
Amvescap Plc.5.07%
American Century Companies Inc4.82%
Rubric Capital Management LP4.82%

Recent filings & reports

DocumentDate
Material agreement · Q3 FY2027
QUIDELORTHO CORPORATION – FORM 8-K SUMMARY September 23, 2026 --- HEADLINE NUMBERS • Company amended its credit agreement on September 23, 2026 • T
2026-09-23
Quarterly report · Q2 FY2027
QUIDELORTHO CORPORATION - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Total revenues Q2 2026: $630.9 million (vs. $613.9 million Q2 2025, +2.8%) • Total
2026-08-07
Results announced · Q3 FY2027
QUIDELORTHO CORPORATION – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Total Revenue: $630.9 million, +3% reported / +2% constant currency vs
2026-08-06
Board / officer change · Q2 FY2027
QUIDELORTHO CORPORATION - FORM 8-K SUMMARY HEADLINE NUMBERS • New CFO Appointment: Micah Young appointed Chief Financial Officer effective July 6, 2
2026-06-23
Shareholder vote results · Q2 FY2027
QUIDELORTHO CORPORATION (QDEL) - 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Stockholders held on June 16, 2026 • Total votes cast for director
2026-06-16
Quarterly report · Q1 FY2027
QUIDELORTHO CORPORATION – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Total revenues Q1 2026: $619.8 million vs. $692.8 million in Q1 2025 (down 10.5% y
2026-05-06
Results announced · Q2 FY2027
QUIDELORTHO CORPORATION – Q1 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Total revenue: $619.8 million, down 10.5% year-over-year (down 12.6% in consta
2026-05-05
Proxy statement · Q2 FY2027
QUIDELORTHO CORPORATION — 2026 PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Election of 10 Director Nominees — Vote FOR ALL
2026-04-27

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Quidel Corporation — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-10-19.